Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Developmental Brain Research
- Vol. 156 (2) , 193-201
- https://doi.org/10.1016/j.devbrainres.2005.02.016
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Ontogeny of PACAP and PACAP Receptors in the Rat Brain: Role of PACAP in the Cerebellum during DevelopmentaAnnals of the New York Academy of Sciences, 2006
- Specification of catecholaminergic and serotonergic neuronsNature Reviews Neuroscience, 2002
- Pituitary Adenylate Cyclase Activating Polypeptide Anti-Mitogenic Signaling in Cerebral Cortical Progenitors Is Regulated by p57Kip2-Dependent CDK2 ActivityJournal of Neuroscience, 2002
- Transcriptional and post-transcriptional regulation of Tyrosine Hydroxylase messenger RNA in PC12 cells during persistent stimulation by VIP and PACAP38: differential regulation by protein kinase A and protein kinase C -dependent pathwaysNeuropeptides, 2002
- Molecular Cloning of Chicken Vasoactive Intestinal Polypeptide Receptor Complementary DNA, Tissue Distribution and Chromosomal Localization1Biology of Reproduction, 2001
- Dopaminergic retinal cell differentiation in culture: modulation by forskolin and dopamineEuropean Journal of Neuroscience, 2001
- Stem Cells and Pattern Formation in the Nervous SystemNeuron, 2001
- Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblastsNeuroscience, 1997
- Histogenesis and topographical distribution of tyrosine hydroxylase immunoreactive amacrine cells in the developing chick retinaDevelopmental Brain Research, 1993
- A Protein Binding Assay for Adenosine 3′:5′-Cyclic MonophosphateProceedings of the National Academy of Sciences, 1970